The value of methotrexate in dermatomyositis

J Am Acad Dermatol. 1998 Jan;38(1):130-2. doi: 10.1016/s0190-9622(98)70562-6.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Administration, Oral
  • Antidotes / therapeutic use
  • Aspartate Aminotransferases / blood
  • Biopsy
  • Dermatologic Agents / administration & dosage
  • Dermatologic Agents / adverse effects
  • Dermatologic Agents / therapeutic use*
  • Dermatomyositis / drug therapy*
  • Folic Acid / therapeutic use
  • Hematinics / therapeutic use
  • Humans
  • Leucovorin / therapeutic use
  • Liver / drug effects
  • Liver / enzymology
  • Liver / pathology
  • Methotrexate / administration & dosage
  • Methotrexate / adverse effects
  • Methotrexate / therapeutic use*
  • Risk Factors

Substances

  • Antidotes
  • Dermatologic Agents
  • Hematinics
  • Folic Acid
  • Aspartate Aminotransferases
  • Leucovorin
  • Methotrexate